bpc-157 safety adverse effects human case report BPC-157: Miracle Healing Peptide or Hidden Danger? BPC-157 Side Effects and Safety:

Additional lumbar fusion surgery improved the gait, and 9 years and 5 months after lumbar fusion surgery spasticity continued to be well controlled with ITB therapy

Why it was included in the FDA ban The FDA cites significant safety risks due to the potential for congestive heart failure in certain patients seen in a clinical trial that was terminated

While there is now little doubt that a degenerative process operates not only in the later progressive phase of the disease, but also likely from the earliest stages of relapsing inflammatory presentations, what is fiercely debated is whether a primary autoimmune inflammation also drives the continuing CNS cytodegeneration and CNS atrophy (Sen et al., 2020

Patients with polycythemia vera a blood disorder involving overproduction of red blood cells face additional risks since B12 stimulates red blood cell production